A proposal for new diagnostic criteria for ALS
暂无分享,去创建一个
D. Burke | M. Swash | W. Paulus | A. Al-Chalabi | O. Hardiman | A. Eisen | M. Turner | M. Carvalho | J. Shefner | H. Mitsumoto | J. Grosskreutz | J. M. Matamala | K. Talbot | Y. Ugawa | R. Kaji | M. Kiernan | N. Simon | S. Vucic | M. Baker | R. Verdugo | L. V. D. Berg | R. Henderson | L. Cui | L. Berg | M. Turner
[1] L. H. van den Berg,et al. Primary lateral sclerosis: consensus diagnostic criteria , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[2] M. Swash,et al. Diagnostic criteria for amyotrophic lateral sclerosis: A multicentre study of inter-rater variation and sensitivity , 2019, Clinical Neurophysiology.
[3] M. Kiernan,et al. Fasciculation intensity and disease progression in amyotrophic lateral sclerosis , 2018, Clinical Neurophysiology.
[4] M. Turner. Progress and new frontiers in biomarkers for amyotrophic lateral sclerosis. , 2018, Biomarkers in medicine.
[5] T. Hortobágyi,et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[6] M. Gaweł,et al. Are we really closer to improving the diagnostic sensitivity in ALS patients with Awaji criteria? , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[7] M. Carvalho. Does Awaji decrease diagnostic yield in ALS , 2012 .
[8] M. de Carvalho. Does Awaji decrease diagnostic yield in ALS? , 2012, Muscle & nerve.
[9] Michael Benatar,et al. Electrical impedance myography as a biomarker to assess ALS progression , 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[10] S. Tsuji,et al. Fasciculation potentials in amyotrophic lateral sclerosis and the diagnostic yield of the Awaji algorithm , 2012, Muscle & nerve.
[11] Martin R. Turner,et al. Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations , 2011, Nature Reviews Neurology.
[12] Massimo Filippi,et al. Towards a neuroimaging biomarker for amyotrophic lateral sclerosis , 2011, The Lancet Neurology.
[13] M. Zwarts,et al. Sensitivity and specificity of the ‘Awaji’ electrodiagnostic criteria for amyotrophic lateral sclerosis: Retrospective comparison of the Awaji and revised El Escorial criteria for ALS , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[14] M. Swash,et al. Electrodiagnostic criteria for diagnosis of ALS , 2008, Clinical Neurophysiology.
[15] O. Hardiman,et al. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. , 2000, Archives of neurology.
[16] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[17] Mamede de Carvalho, Carla Bentes, Teresinha Evangelista,. Fibrillation and sharp-waves: Do we need them to diagnose ALS? , 2000 .
[18] B. Brooks,et al. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[19] M. de Carvalho,et al. Fibrillation and sharp-waves: do we need them to diagnose ALS? , 1999, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.